- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03506919
Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine Arthitec 1 and Arthitec 2 With Allopathic Medicine for the Management of Arthritis
Study Overview
Detailed Description
Although there are more than 100 different kinds of arthritis, the three most common are gout, osteoarthritis (OA) and rheumatoid arthritis (RA).Gout occurs in response to the presence of monosodium urate (MSU) crystals in joints, bones and soft tissues, and is usually treated by non-steroidal anti-inflammatory drugs (NSAIDs), oral or intravenous colchicines, and oral, intravenous or intraarticular glucocorticoids. All these drugs can abort acute attacks, but they also may have severe side effects. OA results from articular cartilage failure induced by a combination of genetic, metabolic, biochemical and biomechanical factors. OA is normally treated with analgesics such as acetaminophen and opioids, NSAIDs, and intraarticular therapies such as glucocorticoids and hyaluronans.
In RA, 75% of the sufferers are women, suggesting the importance of hormones in the etiology of the disease. Smoking and stress are also thought to contribute to this disease, which is characterized by joint stiffness and swelling, often in a symmetrical pattern on both sides of the body. The goals of management of patients with RA are to control pain and swelling, delay disease progression, minimize disability, and improve quality of life. For pain control and swelling, treatment includes analgesics such as acetaminophen and opioids, NSAIDs, and intra-articular therapies such as glucocorticoids. In addition, disease modifying anti-rheumatic drugs (DMARDs) are used to modify the clinical and radiological course of RA. Examples include methotrexate (MTX), sulfasalazine, leflunomide, hydroxychloroquine and newer therapies such as anti-tumor necrosis factor (TNF)-a therapy (etanercept, infliximab and adalimumab), anti-CD20 therapy (rituximab) and abatacept However, all of these agents are associated with numerous side effects Promising evidence has been found for the effective use of some herbal preparations in the treatment of arthritis. Furthermore, evidence suggesting that some herbal preparations reduce consumption of non-steroidal anti-inflammatory drugs. It has been evident that some herbal preparations (Tripterygium wilfordii Hook F) monotherapy is not inferior then methotrexate and in combination with methotrexate showed better result than alone. In addition, adverse effect associated with trials of herbal preparation for arthritis is not only fewer but also minor. Evidence-based complementary and alternative medicine treatments are remarkably successful in addressing not only chronic but acute health issues as well. It is strongly perceived that different complementary and alternative medicine treatments exerts their healing potential by influencing immune system.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Punjab
-
Bahawalpur, Punjab, Pakistan, 062
- Recruiting
- clinical trial was conducted in Bahawalpur, and Rawalpindi
-
Contact:
- Muhammad Asif, Ph.D
- Phone Number: 923346911256
- Email: doctor.asif101@gmail.com
-
Principal Investigator:
- Muhamamd Bilal, M. PHil
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients suffering from Arthritis
Exclusion Criteria:
- Patients with Hypertension, Cardiovascular disorders and Kidney disorders were excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arthitec 1
|
Allopurinol is used to treat gout and certain types of kidney stones.
It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy.
These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells.
Allopurinol works by reducing the amount of uric acid made by the body.
Increased uric acid levels can cause gout and kidney problems
|
Experimental: Arthitec 2
|
Allopurinol is used to treat gout and certain types of kidney stones.
It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy.
These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells.
Allopurinol works by reducing the amount of uric acid made by the body.
Increased uric acid levels can cause gout and kidney problems
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in Serum Uric Acid level
Time Frame: 8 weeks
|
Reduction in Serum Uric Acid level will be monitored after 8 weeks.
Increase level of Serum Uric acid is the major cause of Gouty arthritis which is more prevalent in South-Asian countries.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 003 (NuSkin International)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment of Arthritis
-
Tanta UniversityRecruitingthe Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of SacroiliitisEgypt
-
Assistance Publique Hopitaux De MarseilleCompletedthe Treatment of Knee OsteoarthritisFrance
-
Bios-Therapy, Physiological Systems for Health...Iqvia Pty LtdRecruitingthe Treatment of Knee OsteoarthritisItaly
-
SPS srlNot yet recruitingTreatment of Degenerative Diseases of the SpineItaly
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA); Richmond Behavioral Health Authority...CompletedQuality of Treatment ServicesUnited States
-
Samara State Medical UniversityEnrolling by invitation
-
OctapharmaCompletedReversal of Anticoagulant TreatmentUnited States
-
Seoul National University HospitalCompletedCatheterization | Complication of TreatmentKorea, Republic of
-
University of Sao PauloCompletedEndodontic Treatment of Primary TeethBrazil
-
Roxane LaboratoriesCompletedShort Term Treatment of InsomniaUnited States
Clinical Trials on Allopurinol
-
Ardea Biosciences, Inc.Completed
-
Urica Therapeutics Inc.RecruitingHyperuricemia | GoutUnited States
-
Ardea Biosciences, Inc.Quotient ClinicalCompleted
-
AstraZenecaParexelCompletedChronic Kidney DiseaseGermany
-
Universita di VeronaCompletedChronic Heart FailureItaly
-
Ardea Biosciences, Inc.Completed
-
University of DundeeCompleted
-
Ardea Biosciences, Inc.Completed
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Elevated Serum Uric AcidUnited States, Canada